Litigation Details for Sanofi-Aventis U.S. LLC v. MSN Pharmaceuticals, Inc. (D. Del. 2020)
✉ Email this page to a colleague
Sanofi-Aventis U.S. LLC v. MSN Pharmaceuticals, Inc. (D. Del. 2020)
Docket | ⤷ Sign Up | Date Filed | 2020-05-14 |
Court | District Court, D. Delaware | Date Terminated | 2020-08-11 |
Cause | 35:271 Patent Infringement | Assigned To | Richard Gibson Andrews |
Jury Demand | None | Referred To | |
Parties | SANOFI-AVENTIS U.S. LLC | ||
Patents | 10,583,110 | ||
Attorneys | Whitney L. Meier | ||
Firms | Stamoulis & Weinblatt LLC | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in Sanofi-Aventis U.S. LLC v. MSN Pharmaceuticals, Inc.
Details for Sanofi-Aventis U.S. LLC v. MSN Pharmaceuticals, Inc. (D. Del. 2020)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
0000-00-00 | External link to document | |||
2020-08-20 | 23 | Patent/Trademark Report to Commissioner of Patents | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,583,110 B2. (Attachments: …2020 11 August 2020 1:20-cv-00646 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |